MASLD treatment—a shift in the paradigm is imminent
Mariana Verdelho Machado · 2023
Read MASLD treatment—a shift in the paradigm is imminent by Mariana Verdelho Machado (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10749497.txt.
Description
Mariana Verdelho Machado argued in 2023 that treatment of fatty liver disease tied to metabolic dysfunction stands on the edge of a revolution. The condition, now called MASLD, is swelling toward the top cause of end-stage liver disease. Weight loss remains the most effective therapy, and its tools are escalating fast.
Care is shifting from lifestyle advice to surgery and endoscopy, and now to anti-obesity drugs that rival surgery's results. Patients whose livers are already scarred need liver-directed drugs on top. Machado predicts a disruption on the scale of the hepatitis C cure era a decade ago. The essay is a call to prepare clinics for combination, staged care. It frames the coming drugs as a paradigm shift, not an increment.
Catalog record
| CREATOR | Mariana Verdelho Machado |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |